Ignite Creation Date:
2025-12-24 @ 10:54 PM
Ignite Modification Date:
2026-04-08 @ 11:13 PM
Study NCT ID:
NCT01526369
Status:
COMPLETED
Last Update Posted:
2025-05-09
First Post:
2012-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer
Sponsor:
Cancer Trials Ireland
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
CTRIAL-IE (ICORG) 11-10
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None